

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.31811500 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.31811500 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.94073916 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.94073916 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.36746551 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 5.86897090 |
| 7 | exogenous drug catabolic process (GO:0042738) | 5.70661771 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.65070114 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.65070114 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.65070114 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.45296037 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.42531672 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.41171818 |
| 14 | regulation of plasminogen activation (GO:0010755) | 5.38399367 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.27278113 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.26378286 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.19679791 |
| 18 | blood coagulation, intrinsic pathway (GO:0007597) | 5.11092840 |
| 19 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.09516990 |
| 20 | omega-hydroxylase P450 pathway (GO:0097267) | 4.95335400 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.94845803 |
| 22 | protein carboxylation (GO:0018214) | 4.94845803 |
| 23 | urea metabolic process (GO:0019627) | 4.89597398 |
| 24 | urea cycle (GO:0000050) | 4.89597398 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88091995 |
| 26 | complement activation, alternative pathway (GO:0006957) | 4.86682894 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 4.82565249 |
| 28 | cysteine metabolic process (GO:0006534) | 4.77777042 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.70247572 |
| 30 | bile acid metabolic process (GO:0008206) | 4.68835664 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.65240129 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.63412733 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.55303052 |
| 34 | regulation of fibrinolysis (GO:0051917) | 4.54311150 |
| 35 | ethanol metabolic process (GO:0006067) | 4.53284911 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.52262248 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.50721966 |
| 38 | lysine metabolic process (GO:0006553) | 4.49633543 |
| 39 | lysine catabolic process (GO:0006554) | 4.49633543 |
| 40 | plasma lipoprotein particle organization (GO:0071827) | 4.46511454 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.43855916 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.42352219 |
| 43 | regulation of complement activation (GO:0030449) | 4.34473380 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.32106431 |
| 45 | bile acid and bile salt transport (GO:0015721) | 4.29145182 |
| 46 | * triglyceride homeostasis (GO:0070328) | 4.29061486 |
| 47 | * acylglycerol homeostasis (GO:0055090) | 4.29061486 |
| 48 | acute-phase response (GO:0006953) | 4.24822912 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.20530681 |
| 50 | protein-lipid complex subunit organization (GO:0071825) | 4.20473771 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.19187013 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.19094034 |
| 53 | reverse cholesterol transport (GO:0043691) | 4.19029492 |
| 54 | regulation of cholesterol esterification (GO:0010872) | 4.16363830 |
| 55 | low-density lipoprotein particle remodeling (GO:0034374) | 4.14016968 |
| 56 | phospholipid efflux (GO:0033700) | 4.13603928 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.12056069 |
| 58 | protein-lipid complex assembly (GO:0065005) | 4.09707045 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.04462301 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 4.02907240 |
| 61 | macromolecular complex remodeling (GO:0034367) | 4.02907240 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 4.02907240 |
| 63 | regulation of cholesterol homeostasis (GO:2000188) | 4.00353862 |
| 64 | negative regulation of hemostasis (GO:1900047) | 4.00265173 |
| 65 | negative regulation of blood coagulation (GO:0030195) | 4.00265173 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 3.97657268 |
| 67 | negative regulation of sterol transport (GO:0032372) | 3.97657268 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.97449996 |
| 69 | regulation of apoptotic cell clearance (GO:2000425) | 3.96841824 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 3.91701461 |
| 71 | negative regulation of protein activation cascade (GO:2000258) | 3.89518018 |
| 72 | intestinal cholesterol absorption (GO:0030299) | 3.85954238 |
| 73 | amine catabolic process (GO:0009310) | 3.85843745 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.85843745 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.84546969 |
| 76 | regulation of bile acid biosynthetic process (GO:0070857) | 3.82546781 |
| 77 | intestinal absorption (GO:0050892) | 3.81566430 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.81260396 |
| 79 | drug catabolic process (GO:0042737) | 3.80006586 |
| 80 | diacylglycerol metabolic process (GO:0046339) | 3.76925504 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.76767007 |
| 82 | glutamate metabolic process (GO:0006536) | 3.75463474 |
| 83 | drug transmembrane transport (GO:0006855) | 3.70548516 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 3.70467349 |
| 85 | cholesterol efflux (GO:0033344) | 3.69846256 |
| 86 | phenylpropanoid metabolic process (GO:0009698) | 3.68756455 |
| 87 | negative regulation of coagulation (GO:0050819) | 3.68008244 |
| 88 | cellular glucuronidation (GO:0052695) | 3.67466337 |
| 89 | fatty acid oxidation (GO:0019395) | 3.65154668 |
| 90 | short-chain fatty acid metabolic process (GO:0046459) | 3.64786986 |
| 91 | regulation of humoral immune response (GO:0002920) | 3.62891451 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.58002195 |
| 93 | organic acid catabolic process (GO:0016054) | 3.58002195 |
| 94 | lipid oxidation (GO:0034440) | 3.57739616 |
| 95 | positive regulation of hemostasis (GO:1900048) | 3.57600831 |
| 96 | positive regulation of blood coagulation (GO:0030194) | 3.57600831 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.55355474 |
| 98 | negative regulation of wound healing (GO:0061045) | 3.55354970 |
| 99 | glycine metabolic process (GO:0006544) | 3.54981410 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 3.54299698 |
| 101 | ketone body metabolic process (GO:1902224) | 3.54192745 |
| 102 | ethanol oxidation (GO:0006069) | 3.53529894 |
| 103 | monocarboxylic acid catabolic process (GO:0072329) | 3.53098914 |
| 104 | urate metabolic process (GO:0046415) | 3.52981458 |
| 105 | fatty acid catabolic process (GO:0009062) | 3.52197949 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.50585857 |
| 107 | oxidative demethylation (GO:0070989) | 3.48873055 |
| 108 | neutral lipid catabolic process (GO:0046461) | 3.48067694 |
| 109 | acylglycerol catabolic process (GO:0046464) | 3.48067694 |
| 110 | serine family amino acid metabolic process (GO:0009069) | 3.47484634 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.45557490 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.44695959 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.40780298 |
| 114 | sterol homeostasis (GO:0055092) | 3.40505285 |
| 115 | lipoprotein metabolic process (GO:0042157) | 3.37502384 |
| 116 | positive regulation of lipid catabolic process (GO:0050996) | 3.37496204 |
| 117 | complement activation, classical pathway (GO:0006958) | 3.37088873 |
| 118 | triglyceride catabolic process (GO:0019433) | 3.37063027 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.35882138 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.35882138 |
| 121 | aldehyde catabolic process (GO:0046185) | 3.35245537 |
| 122 | valine metabolic process (GO:0006573) | 3.34892484 |
| 123 | complement activation (GO:0006956) | 3.34551438 |
| 124 | arginine metabolic process (GO:0006525) | 3.34390883 |
| 125 | fibrinolysis (GO:0042730) | 3.30772211 |
| 126 | glucuronate metabolic process (GO:0019585) | 3.28491627 |
| 127 | uronic acid metabolic process (GO:0006063) | 3.28491627 |
| 128 | protein activation cascade (GO:0072376) | 3.28234744 |
| 129 | drug metabolic process (GO:0017144) | 3.27276329 |
| 130 | sterol transport (GO:0015918) | 3.27114320 |
| 131 | cholesterol transport (GO:0030301) | 3.27114320 |
| 132 | positive regulation of coagulation (GO:0050820) | 3.26456715 |
| 133 | S-adenosylmethionine metabolic process (GO:0046500) | 3.25629479 |
| 134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.25461665 |
| 135 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.25294264 |
| 136 | negative regulation of complement activation (GO:0045916) | 3.24720390 |
| 137 | proline metabolic process (GO:0006560) | 3.22948545 |
| 138 | regulation of triglyceride metabolic process (GO:0090207) | 3.20781460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.89683442 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.79941782 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.20568317 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.10150385 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.11930057 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.79018786 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.63975159 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05646014 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.57686032 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24761109 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23793796 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7095178 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95006639 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.92483154 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.87542719 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.73173259 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70814143 |
| 18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70675158 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46668616 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41695490 |
| 21 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39294661 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37501580 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33856911 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.31223249 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30623949 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23618863 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.21674413 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17440808 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16436031 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15832177 |
| 31 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12655509 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11687369 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10162984 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08191245 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99501880 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99122651 |
| 37 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96873632 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.94699128 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94136674 |
| 40 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92973457 |
| 41 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.90078412 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88121756 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87916200 |
| 44 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87848404 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86327698 |
| 46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82403306 |
| 47 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.82087374 |
| 48 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.80644093 |
| 49 | ERA_21632823_ChIP-Seq_H3396_Human | 0.80568371 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79669934 |
| 51 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.79655509 |
| 52 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.79509050 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.79468418 |
| 54 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79322390 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.79312138 |
| 56 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79226673 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78988639 |
| 58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78742648 |
| 59 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78560347 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78404553 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.78240167 |
| 62 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.77809569 |
| 63 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 0.77598669 |
| 64 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.77409509 |
| 65 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76822924 |
| 66 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76347804 |
| 67 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76156016 |
| 68 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74944942 |
| 69 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.74852610 |
| 70 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.74678347 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73632487 |
| 72 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.73373339 |
| 73 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.72983674 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 0.72421511 |
| 75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70687747 |
| 76 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.70432240 |
| 77 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68918241 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68810342 |
| 79 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.68638000 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.67789422 |
| 81 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67377866 |
| 82 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.66549225 |
| 83 | SA1_27219007_Chip-Seq_Bcells_Human | 0.66332069 |
| 84 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66320393 |
| 85 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.65303425 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64579452 |
| 87 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.63018336 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62964090 |
| 89 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.62570072 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.62064574 |
| 91 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.61806536 |
| 92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60853275 |
| 93 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.60665815 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60111362 |
| 95 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.59812753 |
| 96 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.59199239 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.59127781 |
| 98 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.58206080 |
| 99 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.57038780 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56339948 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55366553 |
| 102 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55147577 |
| 103 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.54396259 |
| 104 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.54396259 |
| 105 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.54021207 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.53929413 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53899084 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53899084 |
| 109 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.53777515 |
| 110 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53444778 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.53392041 |
| 112 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.53318527 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.51657915 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51500299 |
| 115 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50600299 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.49699894 |
| 117 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49283831 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.49095683 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.48637887 |
| 120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.48041570 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47909097 |
| 122 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47834582 |
| 123 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.47714938 |
| 124 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47656775 |
| 125 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.46439112 |
| 126 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.46397421 |
| 127 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45841603 |
| 128 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.44979509 |
| 129 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.44740347 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44375841 |
| 131 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.43733704 |
| 132 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.43591758 |
| 133 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.43562400 |
| 134 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.43406158 |
| 135 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.43013933 |
| 136 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.42834791 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41933585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.68955553 |
| 2 | MP0005360_urolithiasis | 6.76115621 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.91907764 |
| 4 | MP0005365_abnormal_bile_salt | 5.84309932 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.52670607 |
| 6 | MP0003252_abnormal_bile_duct | 4.13498238 |
| 7 | MP0003195_calcinosis | 3.58140161 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.56559804 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.31418300 |
| 10 | MP0009840_abnormal_foam_cell | 2.94668807 |
| 11 | MP0005083_abnormal_biliary_tract | 2.76207478 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.66935097 |
| 13 | MP0005332_abnormal_amino_acid | 2.60427112 |
| 14 | * MP0002118_abnormal_lipid_homeostasis | 2.18733958 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.14711142 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.13440782 |
| 17 | MP0003122_maternal_imprinting | 2.13331256 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.10144280 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.07248586 |
| 20 | MP0003868_abnormal_feces_composition | 1.95446119 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.72869535 |
| 22 | MP0004043_abnormal_pH_regulation | 1.72388801 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.67385860 |
| 24 | MP0005220_abnormal_exocrine_pancreas | 1.61946048 |
| 25 | MP0001764_abnormal_homeostasis | 1.56578410 |
| 26 | MP0005670_abnormal_white_adipose | 1.56095113 |
| 27 | MP0003283_abnormal_digestive_organ | 1.51206196 |
| 28 | * MP0002078_abnormal_glucose_homeostasis | 1.47453684 |
| 29 | MP0003879_abnormal_hair_cell | 1.41959195 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.38683075 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.37242329 |
| 32 | MP0002693_abnormal_pancreas_physiology | 1.36127972 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.34045398 |
| 34 | MP0000566_synostosis | 1.28509969 |
| 35 | MP0002928_abnormal_bile_duct | 1.20923104 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.18297046 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.13558646 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.12951428 |
| 39 | MP0005451_abnormal_body_composition | 1.11269046 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.08646180 |
| 41 | * MP0000598_abnormal_liver_morphology | 1.07212284 |
| 42 | MP0009697_abnormal_copulation | 1.04315900 |
| 43 | MP0003186_abnormal_redox_activity | 1.02389220 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.01555076 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.00928676 |
| 46 | * MP0009642_abnormal_blood_homeostasis | 1.00514579 |
| 47 | MP0002876_abnormal_thyroid_physiology | 0.99838568 |
| 48 | * MP0005535_abnormal_body_temperature | 0.93366669 |
| 49 | MP0001756_abnormal_urination | 0.93131262 |
| 50 | MP0005666_abnormal_adipose_tissue | 0.91710402 |
| 51 | * MP0002971_abnormal_brown_adipose | 0.91313976 |
| 52 | MP0004130_abnormal_muscle_cell | 0.90969516 |
| 53 | MP0003123_paternal_imprinting | 0.90622807 |
| 54 | MP0001661_extended_life_span | 0.90525594 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 0.89862722 |
| 56 | MP0002909_abnormal_adrenal_gland | 0.89847956 |
| 57 | MP0002132_abnormal_respiratory_system | 0.88967524 |
| 58 | * MP0005334_abnormal_fat_pad | 0.88961602 |
| 59 | MP0005058_abnormal_lysosome_morphology | 0.85946562 |
| 60 | MP0005647_abnormal_sex_gland | 0.85648917 |
| 61 | MP0005448_abnormal_energy_balance | 0.84825951 |
| 62 | * MP0003953_abnormal_hormone_level | 0.83045725 |
| 63 | MP0008872_abnormal_physiological_respon | 0.82950332 |
| 64 | MP0008469_abnormal_protein_level | 0.82650788 |
| 65 | * MP0009763_increased_sensitivity_to | 0.82143589 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.80786953 |
| 67 | MP0005408_hypopigmentation | 0.77221518 |
| 68 | MP0003300_gastrointestinal_ulcer | 0.76577050 |
| 69 | MP0010368_abnormal_lymphatic_system | 0.76111015 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 0.74729833 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.73045401 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.72758852 |
| 73 | MP0001765_abnormal_ion_homeostasis | 0.72292232 |
| 74 | MP0000604_amyloidosis | 0.71910107 |
| 75 | MP0009764_decreased_sensitivity_to | 0.71794400 |
| 76 | MP0002254_reproductive_system_inflammat | 0.70460560 |
| 77 | MP0003011_delayed_dark_adaptation | 0.70336564 |
| 78 | MP0000639_abnormal_adrenal_gland | 0.69369134 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.66916707 |
| 80 | MP0005376_homeostasis/metabolism_phenot | 0.66014559 |
| 81 | MP0002089_abnormal_postnatal_growth/wei | 0.65225557 |
| 82 | MP0005551_abnormal_eye_electrophysiolog | 0.63295899 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.63007123 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.62729062 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.60735373 |
| 86 | MP0005266_abnormal_metabolism | 0.60378291 |
| 87 | MP0003724_increased_susceptibility_to | 0.59991330 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.59698514 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.58915015 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.58576657 |
| 91 | MP0000678_abnormal_parathyroid_gland | 0.57568821 |
| 92 | MP0009672_abnormal_birth_weight | 0.57089396 |
| 93 | * MP0005452_abnormal_adipose_tissue | 0.53668249 |
| 94 | MP0004270_analgesia | 0.53101719 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.53081184 |
| 96 | MP0000462_abnormal_digestive_system | 0.52959978 |
| 97 | MP0005646_abnormal_pituitary_gland | 0.51917720 |
| 98 | MP0003329_amyloid_beta_deposits | 0.50493950 |
| 99 | MP0002168_other_aberrant_phenotype | 0.49760624 |
| 100 | MP0003075_altered_response_to | 0.49627614 |
| 101 | MP0002638_abnormal_pupillary_reflex | 0.48788637 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.48276924 |
| 103 | * MP0002970_abnormal_white_adipose | 0.48177953 |
| 104 | MP0000579_abnormal_nail_morphology | 0.47162484 |
| 105 | MP0003959_abnormal_lean_body | 0.47132171 |
| 106 | MP0003633_abnormal_nervous_system | 0.46266524 |
| 107 | MP0005395_other_phenotype | 0.45944745 |
| 108 | MP0005464_abnormal_platelet_physiology | 0.44684779 |
| 109 | MP0001915_intracranial_hemorrhage | 0.44562751 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.44063321 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.43656993 |
| 112 | MP0003690_abnormal_glial_cell | 0.42838552 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.42360930 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.41614051 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.40805993 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.40119166 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.39693099 |
| 118 | MP0002269_muscular_atrophy | 0.39634734 |
| 119 | MP0009115_abnormal_fat_cell | 0.39073340 |
| 120 | MP0001501_abnormal_sleep_pattern | 0.38738238 |
| 121 | MP0005409_darkened_coat_color | 0.38328039 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.38051633 |
| 123 | MP0005377_hearing/vestibular/ear_phenot | 0.37414139 |
| 124 | MP0003878_abnormal_ear_physiology | 0.37414139 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.35049933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.06200465 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.33530008 |
| 3 | Hypoglycemic coma (HP:0001325) | 6.01553376 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.78151255 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.71245560 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.62318495 |
| 7 | Xanthomatosis (HP:0000991) | 5.43678061 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.01895250 |
| 9 | Hypoglycemic seizures (HP:0002173) | 4.88185803 |
| 10 | Ketosis (HP:0001946) | 4.78892086 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.77953215 |
| 12 | Complement deficiency (HP:0004431) | 4.73057349 |
| 13 | Ketoacidosis (HP:0001993) | 4.54214438 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.34359821 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.20637077 |
| 16 | Joint hemorrhage (HP:0005261) | 4.04309549 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 4.00638096 |
| 18 | Symptomatic seizures (HP:0011145) | 3.98977868 |
| 19 | Hyperglycinemia (HP:0002154) | 3.97094499 |
| 20 | Hyperammonemia (HP:0001987) | 3.94845079 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.94047142 |
| 22 | Epidermoid cyst (HP:0200040) | 3.92826941 |
| 23 | Hyperglycinuria (HP:0003108) | 3.91496541 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.85357125 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78008086 |
| 26 | Fat malabsorption (HP:0002630) | 3.67800493 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.66585181 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.66585181 |
| 29 | Late onset (HP:0003584) | 3.56668288 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.50105551 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.47689813 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 3.46464526 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45294168 |
| 34 | Abnormality of complement system (HP:0005339) | 3.42197150 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36624425 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.36289525 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.35149792 |
| 38 | Hyperglycemia (HP:0003074) | 3.28252928 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 3.25387312 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 3.16714526 |
| 41 | Gout (HP:0001997) | 3.14353554 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04318418 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.03508674 |
| 44 | Nephritis (HP:0000123) | 3.03488601 |
| 45 | Hypercholesterolemia (HP:0003124) | 2.93409474 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.87660275 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.86841888 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.86841888 |
| 49 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.86501161 |
| 50 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.86501161 |
| 51 | Skin nodule (HP:0200036) | 2.80410343 |
| 52 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.79526202 |
| 53 | Metabolic acidosis (HP:0001942) | 2.73411810 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.58986480 |
| 55 | Myocardial infarction (HP:0001658) | 2.58897025 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.55366684 |
| 57 | Delayed CNS myelination (HP:0002188) | 2.54511919 |
| 58 | Steatorrhea (HP:0002570) | 2.52139892 |
| 59 | Irritability (HP:0000737) | 2.49089514 |
| 60 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.45436860 |
| 61 | Rickets (HP:0002748) | 2.45059802 |
| 62 | Glomerulonephritis (HP:0000099) | 2.44071420 |
| 63 | Purpura (HP:0000979) | 2.42582581 |
| 64 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.42446170 |
| 65 | Hypophosphatemic rickets (HP:0004912) | 2.41233944 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.40872177 |
| 67 | Gingival bleeding (HP:0000225) | 2.39874537 |
| 68 | Facial shape deformation (HP:0011334) | 2.37466272 |
| 69 | Potter facies (HP:0002009) | 2.37466272 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35816336 |
| 71 | Lethargy (HP:0001254) | 2.35435905 |
| 72 | Insulin resistance (HP:0000855) | 2.32793385 |
| 73 | Abnormality of vitamin metabolism (HP:0100508) | 2.30965906 |
| 74 | Enlarged kidneys (HP:0000105) | 2.30276100 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.29372328 |
| 76 | Mitral stenosis (HP:0001718) | 2.25945283 |
| 77 | Spontaneous abortion (HP:0005268) | 2.24951126 |
| 78 | Pancreatitis (HP:0001733) | 2.23366371 |
| 79 | Pigmentary retinal degeneration (HP:0001146) | 2.22555383 |
| 80 | Hyperphosphaturia (HP:0003109) | 2.20798665 |
| 81 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.17370529 |
| 82 | Glycosuria (HP:0003076) | 2.16034965 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 2.16034965 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 2.13794004 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.12839084 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.12839084 |
| 87 | Alkalosis (HP:0001948) | 2.12693479 |
| 88 | Acute hepatic failure (HP:0006554) | 2.11037604 |
| 89 | Malnutrition (HP:0004395) | 2.08482459 |
| 90 | Renal cortical cysts (HP:0000803) | 2.07920211 |
| 91 | Vascular calcification (HP:0004934) | 2.07430244 |
| 92 | Thrombophlebitis (HP:0004418) | 2.06420986 |
| 93 | Hyperuricemia (HP:0002149) | 2.06252225 |
| 94 | Increased purine levels (HP:0004368) | 2.06252225 |
| 95 | Elevated alkaline phosphatase (HP:0003155) | 2.05655460 |
| 96 | Arthropathy (HP:0003040) | 2.03841538 |
| 97 | Mucopolysacchariduria (HP:0008155) | 2.03742023 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03742023 |
| 99 | Myoglobinuria (HP:0002913) | 2.03672564 |
| 100 | Proximal tubulopathy (HP:0000114) | 2.02653058 |
| 101 | Cholelithiasis (HP:0001081) | 2.02289288 |
| 102 | Cerebral edema (HP:0002181) | 2.01223101 |
| 103 | Sensorimotor neuropathy (HP:0007141) | 2.00579054 |
| 104 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.99729704 |
| 105 | Vomiting (HP:0002013) | 1.99411724 |
| 106 | Menorrhagia (HP:0000132) | 1.98428955 |
| 107 | Brushfield spots (HP:0001088) | 1.95759672 |
| 108 | Acanthocytosis (HP:0001927) | 1.94061101 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93438810 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93438810 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93438810 |
| 112 | Increased serum pyruvate (HP:0003542) | 1.92199514 |
| 113 | Abnormal urine phosphate concentration (HP:0012599) | 1.91935957 |
| 114 | Widely patent fontanelles and sutures (HP:0004492) | 1.90005343 |
| 115 | Neonatal onset (HP:0003623) | 1.89355491 |
| 116 | Limb hypertonia (HP:0002509) | 1.87671092 |
| 117 | Hemorrhage of the eye (HP:0011885) | 1.87653719 |
| 118 | Pulmonary embolism (HP:0002204) | 1.87444422 |
| 119 | Retinal atrophy (HP:0001105) | 1.85928618 |
| 120 | Megaloblastic anemia (HP:0001889) | 1.84639709 |
| 121 | Hypertriglyceridemia (HP:0002155) | 1.82557118 |
| 122 | Hypothermia (HP:0002045) | 1.78193806 |
| 123 | Osteomalacia (HP:0002749) | 1.76820647 |
| 124 | Hypophosphatemia (HP:0002148) | 1.74737651 |
| 125 | Abnormality of glycolysis (HP:0004366) | 1.68803635 |
| 126 | Bifid scrotum (HP:0000048) | 1.68378950 |
| 127 | Fair hair (HP:0002286) | 1.67859739 |
| 128 | Poikilocytosis (HP:0004447) | 1.61707338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.56570380 |
| 2 | BCKDK | 5.02573998 |
| 3 | ERN1 | 4.62183445 |
| 4 | MAPK15 | 3.73712562 |
| 5 | TAOK3 | 3.64126736 |
| 6 | SIK1 | 3.62092354 |
| 7 | FGFR2 | 3.23873912 |
| 8 | FGFR4 | 3.23844182 |
| 9 | PASK | 3.12864782 |
| 10 | NTRK3 | 2.88941636 |
| 11 | FLT3 | 2.68413818 |
| 12 | ACVR1B | 2.15847910 |
| 13 | TRIB3 | 1.98556749 |
| 14 | MST1R | 1.84663729 |
| 15 | IRAK3 | 1.77431072 |
| 16 | PHKG1 | 1.74246763 |
| 17 | PHKG2 | 1.74246763 |
| 18 | FRK | 1.68184125 |
| 19 | ERBB4 | 1.61950966 |
| 20 | PIK3CG | 1.57719898 |
| 21 | PTK6 | 1.53598763 |
| 22 | ICK | 1.50895809 |
| 23 | MAPK11 | 1.40116461 |
| 24 | PKN2 | 1.38832450 |
| 25 | MET | 1.36951985 |
| 26 | HIPK2 | 1.34513974 |
| 27 | CAMK1D | 1.29743283 |
| 28 | EPHA4 | 1.28563020 |
| 29 | MAPKAPK3 | 1.28540598 |
| 30 | LATS1 | 1.28299754 |
| 31 | SGK494 | 1.25995521 |
| 32 | SGK223 | 1.25995521 |
| 33 | MAP2K4 | 1.18031770 |
| 34 | EPHA3 | 1.14045347 |
| 35 | PRKCG | 1.12320003 |
| 36 | PRKAA2 | 1.12265609 |
| 37 | TYRO3 | 1.09204600 |
| 38 | TYK2 | 1.08928978 |
| 39 | GRK1 | 1.07321934 |
| 40 | DYRK1B | 1.06802185 |
| 41 | JAK2 | 1.05204267 |
| 42 | WNK4 | 1.05138870 |
| 43 | MAP3K2 | 1.03218062 |
| 44 | PTK2 | 1.01491014 |
| 45 | WNK1 | 0.98962850 |
| 46 | CAMK1G | 0.98222057 |
| 47 | STK39 | 0.94272675 |
| 48 | IRAK1 | 0.93406227 |
| 49 | DDR2 | 0.92581986 |
| 50 | SGK1 | 0.89302987 |
| 51 | JAK1 | 0.89274750 |
| 52 | MAP2K3 | 0.88725156 |
| 53 | FGFR1 | 0.88263963 |
| 54 | PRKAA1 | 0.87091389 |
| 55 | MAP3K1 | 0.85799737 |
| 56 | PRKG2 | 0.85731653 |
| 57 | EPHB1 | 0.85293222 |
| 58 | PDK1 | 0.84384071 |
| 59 | MAP3K7 | 0.79902417 |
| 60 | PINK1 | 0.79597184 |
| 61 | RIPK1 | 0.79511766 |
| 62 | MAP3K3 | 0.79100182 |
| 63 | STK38L | 0.77829856 |
| 64 | TGFBR2 | 0.77825180 |
| 65 | EPHA2 | 0.77123912 |
| 66 | FER | 0.77091943 |
| 67 | PRKG1 | 0.73543916 |
| 68 | NEK9 | 0.72224314 |
| 69 | TBK1 | 0.71987170 |
| 70 | PDGFRA | 0.71454530 |
| 71 | NTRK1 | 0.70371266 |
| 72 | CSK | 0.69743629 |
| 73 | ERBB2 | 0.68472548 |
| 74 | MAP2K2 | 0.67418452 |
| 75 | GSK3A | 0.65870097 |
| 76 | CAMK1 | 0.65802653 |
| 77 | DAPK2 | 0.63667681 |
| 78 | PRKACG | 0.63208048 |
| 79 | CASK | 0.62370281 |
| 80 | MAP3K10 | 0.60573158 |
| 81 | BMPR1B | 0.60140728 |
| 82 | * PRKACA | 0.59216224 |
| 83 | ADRBK2 | 0.58341659 |
| 84 | RPS6KA3 | 0.57594122 |
| 85 | IRAK2 | 0.56814592 |
| 86 | PRKD3 | 0.56709141 |
| 87 | ZAP70 | 0.54671663 |
| 88 | PDK2 | 0.54473439 |
| 89 | PRKCZ | 0.51551380 |
| 90 | MAP2K6 | 0.51535189 |
| 91 | LMTK2 | 0.51286339 |
| 92 | MAP3K6 | 0.50617569 |
| 93 | IGF1R | 0.50238504 |
| 94 | NTRK2 | 0.49146940 |
| 95 | CSNK1E | 0.49142255 |
| 96 | MTOR | 0.49047654 |
| 97 | PRKCH | 0.48738019 |
| 98 | NUAK1 | 0.48304645 |
| 99 | OBSCN | 0.47884840 |
| 100 | NME1 | 0.47694899 |
| 101 | MAP3K14 | 0.47010766 |
| 102 | ABL2 | 0.46953439 |
| 103 | RET | 0.46341186 |
| 104 | PDPK1 | 0.46119022 |
| 105 | CAMK2D | 0.45061915 |
| 106 | TIE1 | 0.43940348 |
| 107 | CDK12 | 0.42859800 |
| 108 | ITK | 0.42435938 |
| 109 | NLK | 0.41894794 |
| 110 | PIK3CA | 0.41392255 |
| 111 | PAK3 | 0.41211845 |
| 112 | SGK3 | 0.40227390 |
| 113 | CHUK | 0.39222076 |
| 114 | CSNK1A1 | 0.39088305 |
| 115 | JAK3 | 0.39051284 |
| 116 | SIK2 | 0.38078377 |
| 117 | CSNK1D | 0.37502273 |
| 118 | PRKACB | 0.37483686 |
| 119 | MAP4K2 | 0.36365688 |
| 120 | SRC | 0.35774322 |
| 121 | WNK3 | 0.35590948 |
| 122 | TNK2 | 0.34798632 |
| 123 | PRKD2 | 0.33838835 |
| 124 | CAMKK2 | 0.33686526 |
| 125 | CSF1R | 0.33563135 |
| 126 | KDR | 0.32558886 |
| 127 | MAP2K1 | 0.31322401 |
| 128 | AKT3 | 0.30898720 |
| 129 | FGFR3 | 0.30249947 |
| 130 | MAP3K11 | 0.29135151 |
| 131 | CAMK2G | 0.28392380 |
| 132 | SGK2 | 0.28124177 |
| 133 | EIF2AK3 | 0.27625808 |
| 134 | MAPK7 | 0.27215347 |
| 135 | MAPK4 | 0.26485457 |
| 136 | CDC42BPA | 0.25521093 |
| 137 | MAPK12 | 0.24676385 |
| 138 | PDK3 | 0.24372736 |
| 139 | PDK4 | 0.24372736 |
| 140 | CAMK4 | 0.21413993 |
| 141 | CDK6 | 0.21352149 |
| 142 | PRKD1 | 0.19415522 |
| 143 | IKBKE | 0.18652137 |
| 144 | PRKCA | 0.18265508 |
| 145 | MAPK3 | 0.18069906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.96928119 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.49169038 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09981478 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.06055631 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.91817591 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.72139862 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62459534 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62363402 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.54015244 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.43763253 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42809592 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37596875 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34136501 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19861553 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17992603 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.11884781 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.07760954 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.04324888 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97937079 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97415003 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96098101 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90725648 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80703833 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67724796 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64094398 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63941132 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63631337 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61494713 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59844239 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53774422 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51940742 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.50367284 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49143971 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.47227630 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47083711 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46886862 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43018762 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.42895226 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41192896 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40477320 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37482502 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36242413 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36029269 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34990344 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29920910 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.09655211 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03717545 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02928373 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96389036 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93509670 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92189707 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89714527 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89004571 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84373218 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82798351 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76868142 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75742036 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73037698 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70954217 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.70288662 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69289140 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68390546 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66959201 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63611931 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61102837 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.60301951 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59946264 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50898032 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49457439 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47750710 |
| 71 | * Insulin resistance_Homo sapiens_hsa04931 | 0.46877962 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46716738 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.46218160 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41953151 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40435014 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38682530 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38071327 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37974820 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37897890 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37562164 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35975218 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32872592 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32600359 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29994645 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25898775 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.25480153 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20500336 |
| 88 | Insulin secretion_Homo sapiens_hsa04911 | 0.20480952 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16741836 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15490238 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.14604490 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14210257 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12615812 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10479711 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09059456 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.08031489 |
| 97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.06257330 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.05502003 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.05330798 |
| 100 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02171234 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.01569479 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.1171242 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1110229 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0888755 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0466461 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0347160 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0190820 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0086402 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0019023 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0015583 |

